GoodRx Holdings (GDRX) Tax Provisions (2019 - 2026)

GoodRx Holdings has disclosed Tax Provisions across 8 years of filings, most recently posting $6.9 million for Q2 2026.

• In Q2 2026, Tax Provisions rose 2.91% year-over-year to $6.9 million; the TTM figure through Jun 2026 stood at $25.1 million (up 18.82% YoY), while the FY2025 annual figure was $26.1 million, up 73.19% from the prior year.
• Tax Provisions came in at $6.9 million for Q2 2026 at GoodRx Holdings, up from $4.5 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $19.5 million in Q3 2022 to a low of -$46.7 million in Q2 2023.
• Average Tax Provisions over 5 years is $859000.0, with a median of $4.6 million recorded in 2024.
• Year-over-year, Tax Provisions plunged 434.29% in 2023 and jumped 331.34% in 2025.
• Over 5 years, Tax Provisions stood at -$2.8 million in 2022, then soared by 144.5% to $1.2 million in 2023, then jumped by 278.36% to $4.7 million in 2024, then soared by 87.79% to $8.8 million in 2025, then dropped by 20.96% to $6.9 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $6.9 million in Q2 2026, $4.5 million in Q1 2026, and $8.8 million in Q4 2025.